Domov › Akutna mieločna levkemija › Florida

Klinične študije za Akutna mieločna levkemija v Florida

55 študij za Akutna mieločna levkemija išče udeležence na lokacijah v Florida.

Mesta v Florida

Uradno besedilo študije (angleško)

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

Moffitt Cancer Center /ID# 279192, Tampa

Vključevanje udeležencevFaza 2/3

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07581002

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
Morton Plant Hospital, Clearwater
in še 11

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Moffitt Cancer Center, Tampa

Vključevanje udeležencevFaza 1

Starost 12–78 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT03802695

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Miami Cancer Institute, Miami
Memorial Hospital West, Pembroke Pines

Vključevanje udeležencevFaza 2

Starost 18–59 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Florida Cancer Specialists & Research Institute, Fort Myers
Jupiter Research, Jupiter
AdventHealth Medical Group Blood & Marrow Transplant at Orlando, Orlando
in še 4

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06852222

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

UF Health Cancer Institute - Gainesville, Gainesville
Mayo Clinic in Florida, Jacksonville
Miami Cancer Institute, Miami
in še 2

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

UF Health Cancer Institute - Gainesville, Gainesville
Miami Cancer Institute, Miami

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06317649

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
Miami Cancer Institute, Miami
Memorial Hospital West, Pembroke Pines

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Mayo Clinic in Florida, Jacksonville
Miami Cancer Institute, Miami
Memorial Hospital West, Pembroke Pines

Vključevanje udeležencevFaza 2

Starost 18–59 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Golisano Children's Hospital of Southwest Florida, Fort Myers
UF Health Cancer Institute - Gainesville, Gainesville
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
in še 10

Vključevanje udeležencevFaza 3

6 Months – 21 Years · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT04293562

Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT06504459

A Study of BGB-11417 in Participants With Myeloid Malignancies

Tampa General Hospital, Tampa

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT04771130

A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)

Moffitt Cancer Center, Tampa

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT06616636

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

Moffitt Cancer Center and Research Institute Hospital, Tampa

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT06969430

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Golisano Children's Hospital of Southwest Florida, Fort Myers
Nemours Children's Clinic-Jacksonville, Jacksonville
Nemours Children's Hospital, Orlando
in še 1

Vključevanje udeležencevFaza 3

Starost 1–25 · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07022678

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Mayo Clinic, Jacksonville
Moffitt Cancer Center, Tampa

Vključevanje udeležencevFaza 1/2

Starost 12 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT04588922

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

US-Jacksonville FL-MAYOFL, Jacksonville

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06652438

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

US-Orlando FL-ORLANDOHEALTH, Orlando

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07223814

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

University of Florida, Gainesville

Vključevanje udeležencevFaza 1/2Vabljeni zdravi prostovoljci

Do 50 let · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT05322850

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

Moffitt Cancer Center, Tampa

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT06533761

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
in še 2

Vključevanje udeležencevFaza 1

Starost 18–75 · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT05886049

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Broward Health Medical Center, Fort Lauderdale
Golisano Children's Hospital of Southwest Florida, Fort Myers
UF Health Cancer Institute - Gainesville, Gainesville
in še 9

Vključevanje udeležencevFaza 1/2

Do 22 let · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Golisano Children's Hospital of Southwest Florida, Fort Myers
University of Florida Health Shands Children's Hospital, Gainesville
Nemours Children's Specialty Care Jacksonville, Jacksonville
in še 2

Vključevanje udeležencevFaza 3

29 Days – 21 Years · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

University of Miami, Miami
Moffitt Cancer Center & Research Institute, Tampa

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT07007312

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

H Lee Moffitt Cancer Center & Research Institute, Tampa

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT06656494

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

University of Miami, Miami

Vključevanje udeležencev

Starost 18 in več · Vsi spoli · Posodobljeno 13. avg. 2026 · NCT07469592

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

Bioresearch Partners, Miami

Vključevanje udeležencevFaza 2/3

Starost 18–80 · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT06788756

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Moffitt Cancer Center, Tampa

Vključevanje udeležencevFaza 3

Starost 18–75 · Vsi spoli · Posodobljeno 17. jul. 2026 · NCT05429632

Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents

University of Miami, Miami
AdventHealth Orlando, Orlando

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 10. jul. 2026 · NCT05442216

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Moffitt Cancer Center, Tampa

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

University of Florida Shands Medical Center, Gainesville
Nemours Children's Hospital - Mayo Jacksonville, Jacksonville
University of Miami (peds), Miami
in še 6

Vključevanje udeležencevOpazovalna študija

Vse starosti · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT01351545

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

University of Miami Health System, Coral Gables

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 15. jun. 2026 · NCT05768932

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

University of Florida, Gainesville

Vključevanje udeležencevFaza 2

6 Months – 39 Years · Vsi spoli · Posodobljeno 4. jun. 2026 · NCT05800210

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

University of Miami - Sylvester Comprehensive Cancer Center, Miami

Vključevanje udeležencevFaza 2/3

Starost 18 in več · Vsi spoli · Posodobljeno 30. apr. 2026 · NCT04256317

Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy

University of Miami, Miami

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 16. apr. 2026 · NCT06782542

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

Mayo Clinic Florida, Jacksonville

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 13. apr. 2026 · NCT05732103

BCL2i CLAG-M in R/R Acute Myeloid Leukemia

Moffitt Cancer Center, Tampa

Vključevanje udeležencevFaza 2

Starost 18–80 · Vsi spoli · Posodobljeno 1. apr. 2026 · NCT06660368

Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy

Mayo Clinic in Florida, Jacksonville

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 1. apr. 2026 · NCT06279572

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

University of Miami, Miami
Miami Cancer Institute, Miami
Moffitt Cancer Center, Tampa

Vključevanje udeležencevFaza 1/2

Starost 12 in več · Vsi spoli · Posodobljeno 24. mar. 2026 · NCT04988555

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

University of Miami, Miami

Vključevanje udeležencevFaza 2

Starost 18–66 · Vsi spoli · Posodobljeno 17. mar. 2026 · NCT06859424

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.